Dihydroergocristine mesylate is a methanesulfonic acid salt of dihydroergocristine, an ergot alkaloid derivative. It has been employed as an active pharmaceutical ingredient for symptomatic management of mental decline associated with cerebrovascular insufficiency and in peripheral vascular disease.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 24730-10-7
Dihydroergotamine mesylate
active pharmaceutical ingredient
Dihydro-alpha-ergocryptine mesylate
active pharmaceutical ingredient
(S,E)-N-(4-((4-CHLORO-3-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE
active pharmaceutical ingredient
(-)-Epiafzelechin
active pharmaceutical ingredient (API) standard
Prasteronyl Abiraterone
active pharmaceutical ingredient
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
Abiraterone acetate impurity
Acidihydroergocristine
pharmaceutical reference standard
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
SPXACGZWWVIDGR-SPZWACKZSA-N
CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O